Axsome Therapeutics Inc (AXSM) EPS growth this year is -3.19%: Get Prepared for Trading Lift Off

Axsome Therapeutics Inc (NASDAQ: AXSM) established initial surge of 2.70% at $99.65, before settling in for the price of $97.03 at the close. Taking a more long-term approach, AXSM posted a 52-week range of $61.14-$105.00.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare sector firm’s twelve-monthly sales growth has been 88.16% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -35.53%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -3.19%. This publicly-traded company’s shares outstanding now amounts to $47.35 million, simultaneously with a float of $39.53 million. The organization now has a market capitalization sitting at $4.83 billion. At the time of writing, stock’s 50-day Moving Average stood at $91.37, while the 200-day Moving Average is $82.67.

Axsome Therapeutics Inc (AXSM) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Axsome Therapeutics Inc industry. Axsome Therapeutics Inc’s current insider ownership accounts for 18.44%, in contrast to 79.07% institutional ownership. According to the most recent insider trade that took place on Sep 11 ’24, this organization’s Director sold 11,016 shares at the rate of 91.31, making the entire transaction reach 1,005,871 in total value, affecting insider ownership by 10,002.

Axsome Therapeutics Inc (AXSM) Earnings and Revenue Records

Axsome Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -3.19% and is forecasted to reach -1.47 in the upcoming year.

Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators

Let’s observe the current performance indicators for Axsome Therapeutics Inc (AXSM). It’s Quick Ratio in the last reported quarter now stands at 2.37. The Stock has managed to achieve an average true range (ATR) of 3.68. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 14.27.

In the same vein, AXSM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.54, a figure that is expected to reach -0.96 in the next quarter, and analysts are predicting that it will be -1.47 at the market close of one year from today.

Technical Analysis of Axsome Therapeutics Inc (AXSM)

Now, what If we examine the latest scores posted by [Axsome Therapeutics Inc, AXSM]. During the last 5-days, its volume was lower the volume of 0.62 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 66.81% While, its Average True Range was 3.76.

Raw Stochastic average of Axsome Therapeutics Inc (AXSM) in the period of the previous 100 days is set at 83.68%, which indicates a major rise in contrast to 67.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 48.60% that was higher than 35.53% volatility it exhibited in the past 100-days period.